AI-generated summary
The authors studied whether red laser photobiomodulation combined with radiotherapy affects triple-negative breast cancer in female mice. In this mouse study, they report that laser treatment, regardless of protocol, slowed tumor growth, improved clinical condition and reduced lung metastases, with the highest per-session dose extending survival. The authors suggest the approach could be a potential ally to radiotherapy, but the study is limited to mice.
- Who or what was studied
- Female BALB/c mice with triple-negative breast cancer (T1 cells implanted into a mammary fat pad)
- Limits stated in the abstract
- The study was conducted in mice, and the abstract does not report a participant total or describe human data.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Total energy
- 150 J, 37.5 J
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Photobiomodulation therapy, Laser, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.